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ABSTRACT 
Congenital pancreatic triglyceride lipase (PNLIP) deficiency is a rare disorder with uncertain 
genetic background as most cases were described before gene sequencing was readily 
available.  Recently, two brothers with PNLIP deficiency were found to carry a homozygous 
missense mutation, c.662C>T (p.T221M) in the PNLIP gene (J. Lipid Res. 2014. 55:307-312).  
Molecular modeling suggested the substitution would change the orientation of residues in the 
catalytic site and disrupt the function of p.T221M PNLIP.  To test the effect of the p.T221M 
mutation on PNLIP function, we expressed wild-type and p.T221M PNLIP in human embryonic 
kidney (HEK) 293A cells and dexamethasone-differentiated AR42J rat acinar cells.  In both 
cellular models, wild-type PNLIP was secreted into the conditioned medium where it was readily 
detectable by protein staining, immunoblot or lipase activity assays. In contrast, mutant 
p.T221M was not secreted into the medium, but it was present  in cell lysates where it 
accumulated in the insoluble fraction.  Intracellular retention of mutant p.T221M resulted in 
endoplasmic reticulum (ER) stress as measured by elevated XBP1 splicing and increased levels 
of ER chaperones. Our results demonstrate that the presence of methionine at position 221 in 
the PNLIP protein sequence causes misfolding and aggregation of the p.T221M mutant inside 
the cell. The consequent loss of enzyme secretion adequately explains the clinical phenotype of 
PNLIP deficiency reported for homozygous carriers of p.T221M. Furthermore, the ability of 
mutant p.T221M to induce ER stress suggests that this form of PNLIP deficiency might cause 
acinar cell damage as well. 
  
Keywords: Lipase, fat digestion, protein misfolding, endoplasmic reticulum stress response 
 
  
2 
 
1. Introduction 
Although congenital pancreatic lipase triglyceride (PNLIP) deficiency is discussed in most 
textbooks of pediatric gastroenterology, there are only a few reports of patients with evidence of 
this rare disorder (1-10).  In each case, the PNLIP deficiency was demonstrated by enzymatic 
assay of pancreatic secretions.  In no case, was a mutation in the protein or gene reported.  A 
recent effort to identify mutations in the PNLIP gene of four patients with absent lipase activity in 
their pancreatic fluid failed to find any nonsense or missense mutations that could explain the 
deficiency (11).  Thus, it has never been clear if the absence of PNLIP activity in the pancreatic 
secretion of the reported patients resulted from a gene mutation or another reason such as the 
presence of a lipase inhibitor or technical problems with the sample collection or with the lipase 
assay. 
Recently, Behar et. al. (2014) reported two brothers from a consanguineous marriage who 
had clinical PNLIP deficiency with steatorrhea and a novel homozygous missense mutation in 
the PNLIP gene (12). The heterozygous carrier parents were clinically unaffected. A single base 
substitution in exon 6 (c.662C>T) changed the amino acid at position 221 (p.T221M).  Thr221 is 
conserved in all known PNLIP sequences.  It is located in the β9 loop, which contributes to the 
active site of PNLIP (13).  In the crystal structure of human PNLIP, Thr221 forms a hydrogen 
bond with Asp193, a residue in the Ser-His-Asp catalytic triad (14, 15).  Molecular modeling 
suggests the substitution of Thr221 with the larger amino acid, methionine, destabilizes the 
active site of PNLIP (12).  The authors speculated that the brothers’ steatorrhea resulted from 
decreased activity of p.T221M PNLIP. 
To test the hypothesis that the p.T221M mutation alters PNLIP function, we expressed 
Thr221 PNLIP and Met221 PNLIP in HEK 293A and AR42J cells.  We then determined the 
effect of the p.T221M mutation on PNLIP expression, secretion and activity.  Our results 
demonstrate that the presence of methionine at position 221 in the protein sequence causes 
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misfolding of p.T221M PNLIP.  The misfolded lipase accumulates in the cell, is inactive and is 
not secreted into the medium.   
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2. Materials and methods 
2.1 Nomenclature  
Nucleotide numbering reflects coding DNA numbering with +1 corresponding to the A of the 
ATG translation initiation codon in PNLIP. Amino acid residues are numbered starting with the 
initiator methionine of the primary translation product for human PNLIP. 
 
2.2 Expression Plasmids, Mutagenesis and Adenovirus 
The cDNA encoding human PNLIP was amplified by PCR using our previously obtained full 
length human PNLIP cDNA clone as template and subsequently subcloned into the mammalian 
protein expression vector pcDNA3 (Invitrogen, Carlsbad, CA) (16). The c.662C>T (p.T221M) 
mutation was introduced by overlap extension PCR. The sequence of all plasmid DNA 
constructs was verified by dideoxynucleotide sequencing.  Recombinant adenovirus carrying a 
His-tagged form of wild-type PNLIP or mutant p.T221M was generated by Viraquest, Inc. (North 
Liberty, IA). Control adenovirus was purchased from Viraquest. 
 
2.3 Culture and Transfection of Mammalian Cells  
HEK 293A cells were purchased from ATCC (Manassas, VA) and maintained in DMEM 
supplemented with 10% fetal bovine serum, 1% vol/vol units/ml penicillin and streptomycin 
(#15140-122 GIBCO, Life Technologies, Grand Island, NY) at 37° C in a 5% CO2-humidified 
incubator. Sixteen hours prior to transfection, cells (2 ml/well for 6-well plates and 10 ml/dish for 
10-cm culture dishes) were seeded at 75% confluence. Transfections were carried out using 
FuGENE 6 (Roche Diagnostics, Indianapolis, IN). Briefly, in 100 μl of Opti-MEM I reduced 
serum medium (Invitrogen), 5 μl of FuGENE 6 was mixed with 1.65 μg of plasmid DNA 
(pcDNA3, pcDNA3/PNLIP, or pcDNA3/ PNLIP p.T221M). The mixture was then added to the 
cells in each well of 6-well plates. For RNA extraction, a mixture of 25 μl of FuGENE 6 and 10 
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μg of each plasmid DNA in 500 μl of Opti-MEM I reduced serum medium was added for each 
10-cm dish. 
AR42J rat pancreatic acinar cells (ATCC #CRL-1492) were maintained in DMEM 
supplemented with 20% fetal bovine serum, 4 mM glutamine and 1% vol/vol 
penicillin/streptomycin at 37oC. Prior to transfection, cells were plated in 6-well plates at a 
density of 106 cells per well and were grown in the presence of 100 nM dexamethasone for 48 
h. Transduction with adenovirus were performed in 1 mL OptiMEM containing 100 nM 
dexamethasone using the indicated viral concentrations.  
 
2.4 Collection of Culture Media and Cells  
Seventy-two hours after transfection, conditioned media from HEK 293A cells were 
withdrawn and subjected to 200 g × 5 min centrifugation to obtain cell free conditioned media. 
Cells were washed twice gently with ice-cold PBS and washed off the plates in 1.5 ml of PBS 
and centrifuged at 200 g × 5 min. For whole cell lysates, the resultant cell pellets were 
resuspended in 300 μl of 1 × Laemmli buffer, followed by 3 × 15 sec sonication. Otherwise, cells 
were resuspended in 300 μl of RIPA buffer (150 mM NaCl, 1.0% Nonidet P-40, 0.5% sodium 
deoxycholate, 0.1% SDS, and 50 mM Tris, pH 8.0) supplemented with protease and 
phosphatase inhibitors and incubated on ice for 10 min, followed by 3 × 5 sec sonication. The 
cell lysates were clarified by centrifugation at 16,000 g × 20 min at 4 °C, and the supernatants 
were designated as soluble lysate fraction. The pellets were washed twice with ice-cold PBS 
and followed by 16,000 g × 5 min. The final pellets were resuspended in 100 μl of 1 × Laemmli 
buffer and sonicated until no particle was visible. This part was designated as insoluble lysate 
fraction.  
Conditioned media from AR42J cells were harvested 24 h after transduction.  Cells were 
washed twice with PBS, scraped from the tissue culture plates in 1 ml PBS and centrifuged for 
10 min at  850 g. Cells were resuspended in 200 μl Reporter Lysis Buffer (Promega, Madison, 
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WI) and 2 μl Halt Protease and Phosphatase Inhibitor Single-Use Cocktail (#78442, Pierce - 
Thermo Scientific, Rockford, IL) was added. Cells were incubated on ice for 15 min and the 
lysate was cleared by centrifugation for 10 min at 16,000 g. For all cell lysate samples, the 
protein concentration was measured with the Micro BCA Protein Assay Kit (Pierce - Thermo 
Scientific). 
 
2.5 Measurement of PNLIP protein secretion from AR42J Cells  
Proteins in the conditioned media (40 µl from AR42J cells) were precipitated with 10% 
trichloroacetic acid (final concentration), resuspended in 20 µl Laemmli sample buffer containing 
100 mM dithiothreitol, heat-denatured at 95oC for 5 min and electrophoresed on 15% SDS-
polyacrylamide gels. Gels were stained with Coomassie Blue. 
 
2.6 Lipase Activity Assay  
Lipase activity of human PNLIP was determined at 25 °C by using the standard 5-min pH-
stat method with the emulsion of tributyrin (114 mM) in a total volume of 15 ml. The reactions 
were carried out in the presence or absence of over 5-fold molar excess of colipase at 4 mM 
sodium taurodeoxycholate (NaTDC) concentration. Fifty µl of conditioned medium from HEK 
293A cells or 100 µl of conditioned medium from AR42J cells were added to the reaction. For 
the assay of the soluble cell lysate from HEK 293A cells, 100 µl (total volume of 300 µl) was 
added to the reaction.  Lipase activities are expressed as μmoles of fatty acid released per min. 
 
2.7 Protein Immunoblot  
Conditioned media and cell lysates from HEK 293A cells were treated with 2 × Laemmli 
sample buffer supplemented with 2-mercaptoethanol. After being heated to 95 °C for 5 min, the 
prepared conditioned medium (20 µl) and cell lysate samples (10-30 µg for whole cell lysate and 
soluble fraction and 5-10 µg for insoluble fraction) were resolved on 4-15% Mini-Protean TGX 
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gels (Bio-Rad, Hercules, CA) and transferred onto an Immobilon-P membrane (Millipore, 
Bedford, MA). For AR42J cells, conditioned media (0.1 µl) and cell lysates (0.25 µg total protein 
for His-tag detection, 2.5 µg total protein for α-tubulin detection or 5 µg total protein for PNLIP 
detection) were treated as above and electrophoresed on 15% Tris-glycine minigels and 
transferred onto an Immobilon-P membrane.  After blocking with 5% non-fat milk in PBS 
supplemented with 0.1% Tween 20, the membrane was incubated with primary antibody at 4° C 
overnight and then with secondary antibody for 1 h at room temperature. The bands were 
detected using the SuperSignal West Femto Maximum Sensitivity Substrate or the SuperSignal 
West Pico Chemiluminescent Substrate (Pierce - Thermo Scientific, Rockford, IL). 
Antibodies used in this study were as following: rabbit polyclonal antibody against human 
PNLIP (1:5,000) was produced in our laboratory (17); rabbit anti-BiP (3177; 1:1,000), GRP94 
(2104; 1:1,000), calnexin (2679; 1:2,000), calreticulin (12238; 1:2,000), and rabbit anti-β tubulin 
(2128; 1:5,000) and GAPDH (5174; 1:5,000) were purchased from Cell Signaling (Danvers, 
MA); mouse monoclonal anti-α tubulin antibody (T5168; 1:2,000) was from Sigma-Aldrich (St. 
Louis, MO), and horse-radish peroxidase (HRP)-conjugated mouse monoclonal penta-His 
antibody (34460; 1:2,000) was purchased from Qiagen (Louisville, KY).  The goat anti-rabbit IgG 
conjugated with horseradish peroxidase (31460; 1: 50,000) was purchased from Pierce - 
Thermo Scientific. 
   
2.8 RT-PCR and Real-Time PCR Analysis  
Total RNA was isolated from HEK 293A cells transfected with given plasmid DNAs using 
TRIzol (Invitrogen), and 1.5 μg of RNA was then reverse-transcribed with Moloney murine 
leukemia virus reverse transcription kit from Ambion (Austin, TX) at 44° C for 1 h in a 20-μl 
reaction volume. Semiquantitative measurements were performed by PCR of the X-box binding 
protein-1 (XBP1) cDNA and its spliced form, using the following primers that amplify both forms 
as follows: XBP1 forward primer, 5′-CCT TGT AGT TGA GAA CCA GG-3′, and XBP1 reverse 
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primer, 5′-GGG CTT GGT ATA TAT GTG G-3′. The XBP1 primers amplify 441- and 415-bp 
amplicons from the unspliced and spliced cDNAs, respectively. As an endogenous control, a 
261-bp fragment of GAPDH was also amplified, using the following primers: GAPDH sense 
primer, 5′-GTC CAC TGG CGT CTT CAC CA-3′, and GAPDH antisense primer, 5′-GTG GCA 
GTG ATG GCA TGG AC-3′. PCR products were run on 2% agarose gels, and the bands were 
visualized by ethidium bromide staining. 
Total RNA was extracted from AR42J cell lysates using the RNeasy Plus Mini kit (Qiagen). 
RNA was reverse-transcribed using High Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems, Grand Island, NY). XBP1 splicing was studied by PCR using a primer set forward: 
5’- GCT TGT GAT TGA GAA CCA GG -3’, reverse: 5’- AGG CTT GGT GTA TAC ATG G -3’) 
that flanked the spliced region and amplified both spliced (421 bp) and unspliced (447 bp) 
forms. The PCR products were resolved on 2% agarose gels and stained with ethidium 
bromide. Expression of mRNA for BiP and calreticulin was measured by real time PCR (7500 
Real Time PCR System, Applied Biosystems) using TaqMan primers with TaqMan Universal 
PCR Mastermix (Applied Biosystems). Gene expression was quantitated using the comparative 
CT method (ΔΔCT method). Threshold cycle (CT) values were determined with the 7500 System 
Sequence Detection Software 1.3. Expression levels of target genes were first normalized to the 
GAPDH internal control gene (ΔCT) and then to expression levels measured in cells infected 
with 2×107 pfu/mL control (vector only) adenovirus (ΔΔCT). Results were expressed as fold 
changes calculated with the formula 2-ΔΔCT. 
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3. Results 
3.1 Secretion and Folding of p.T221M PNLIP 
To determine if the p.T221M substitution affects the folding or function of PNLIP, we first 
transfected HEK 293A cells with empty vector, vector containing PNLIP or vector containing 
p.T221M PNLIP.  These cells are relatively easy to culture and can be reproducibly transfected 
with plasmids at high efficiency.  Additionally, they have been used to study secretion of a large 
variety of proteins and represent a good model to study protein secretion.  When we assayed 
conditioned medium from the transfected cells for lipase activity, only the cells transfected with 
PNLIP had detectable activity (Fig. 1A).  The medium from cells transfected p.T221M PNLIP 
had no lipase activity.  We next determined if inactive p.T221M PNLIP was present in the 
conditioned medium by immunoblot analysis with our rabbit anti-human PNLIP antibody (Fig. 1B 
and C).  Whereas PNLIP was detectable in conditioned medium, p.T221M PNLIP was 
undetectable suggesting the mutant lipase was either poorly expressed in HEK 293T cells or not 
secreted by these cells.   
To help distinguish between these possibilities, we next determined if p.T221M PNLIP was 
present inside the transfected cells.  Protein immunoblot analysis of the whole cell lysate 
revealed the presence of both PNLIP and p.T221M PNLIP in the cells (Fig. 2A).  The amount of 
the mutant lipase was significantly higher (P ≤ 0.001).  We then separated the intracellular 
lipase into a soluble and detergent-insoluble fraction by detergent extraction and centrifugation.  
Both lipases were present in the soluble fraction (Fig. 2B).  The amount of soluble p.T221M 
PNLIP was significantly higher than the amount of PNLIP (P ≤ 0.001).  Lipase assay 100 µl of 
the soluble intracellular fraction using tributyrin as substrate revealed an activity of 1.8 ± 0.097 
µmoles fatty acid released per min and no detectable activity in extracts from mock transfected 
or p.T221M PNLIP (n=3) suggesting the soluble p.T221M was in an inactive conformation.  
Importantly, the amount of p.T221M PNLIP in the insoluble fraction was about 7-fold higher than 
the amount of PNLIP (P ≤ 0.001) (Fig. 2C).  In both the soluble fraction and the insoluble 
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fractions we detected higher molecular weight antibody positive proteins migrating above 100 
kDa in the p.T221M samples.  The bands were not present in the PNLIP samples suggesting 
they did not result from non-specific binding of the antibodies.  The nature of these bands was 
not further investigated. 
We repeated these experiments in a rat acinar cell line, AR42J, transduced with 
recombinant adenovirus.  The amount of PNLIP in the medium of transduced AR42J cells 
increased with increasing amounts of adenovirus as determined by lipase assay, by SDS-PAGE 
and protein staining and by protein immunoblot (Fig. 3A).  As found in the HEK 293A cells, 
lipase activity was present in the conditioned medium from cells transduced with PNLIP 
adenovirus but not in cells transduced with p.T221M PNLIP adenovirus.  Similarly, PNLIP 
protein was only detected in the conditioned medium from cells transduced with PNLIP 
adenovirus by protein staining or immunoblot. The amount of PNLIP activity and protein 
increased with increasing amounts of adenovirus in the PNLIP transduced cells. p.T221M 
PNLIP was not detected in conditioned medium by either protein staining or immunoblot. 
Examination of the AR42J cellular fraction revealed the presence of p.T221M PNLIP in the 
cells as seen in the HEK 293A cells (Fig. 3B).  The amount of PNLIP and p.T221M PNLIP in the 
cells varied proportionately with increasing viral titers.  The intracellular recombinant lipases 
were separated into a soluble and an insoluble fraction by centrifugation (Fig. 3C).  As observed 
in the HEK 293A cells, both PNLIP and p.T221M PNLIP were present in the soluble fraction or 
supernatant.  Only a minor portion of PNLIP appeared in the insoluble fraction.  In contrast, a 
significant fraction of the intracellular p.T221M PNLIP was in the insoluble fraction. 
  
3.2 Activation of the ER Stress Response 
The accumulation of intracellular proteins in the detergent-insoluble fraction suggests the 
protein has misfolded and formed insoluble aggregates.  If this is the case, the unfolded protein 
response (UPR) will be activated, a process that can lead to an ER stress response.  To 
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determine if p.T221M PNLIP activates the UPR and ER stress response, we measured the 
protein levels of several major ER chaperones, BiP, calreticulin and GRP94 and the splicing of 
the mRNA encoding XBP1 in transfected HEK 293A cells.  Overexpression of PNLIP and 
p.T221M PNLIP resulted in upregulation of BiP protein levels compared to the vector control (P 
≤ 0.01) (Fig. 4A).  Furthermore, levels of BiP in the cells transfected with p.T221M PNLIP were 
significantly higher than the BiP levels in cells transfected with PNLIP (P ≤ 0.01).  The levels of 
calreticulin were elevated above controls in HEK 293A cells expressing PNLIP or p.T221M 
PNLIP (P ≤ 0.01) but the levels were not different between cells expressing the two recombinant 
lipases (Fig. 4B).  Levels of GRP94 were significantly increased in cells transfected with 
p.T221M PNLIP compared to the levels in control and PNLIP transfected cells (P ≤ 0.01) (Fig. 
4C).  The GRP94 levels in cells expressing PNLIP did not differ from the GRP94 levels in 
control cells.   
Because BiP protein levels were elevated in cells transfected with p.T221M PNLIP, we next 
determined if there was a downstream effect in the UPR.  During ER stress, IRE1 is activated, 
which catalyzes the cytoplasmic splicing of XBP1 mRNA to generate a shorter XBP1 mRNA 
variant.  This variant encodes a transcriptional activator critical for the UPR.  We performed RT-
PCR analysis of XBP1 mRNA in mock, PNLIP and p.T221M PNLIP transfected HEK 293A cells 
(Fig. 4D). Splicing of XBP1 mRNA was increased about 10-fold in cells transfected with 
p.T221M PNLIP compared to the control cells (P ≤ 0.01).  XBP1 mRNA splicing was not 
increased in cells transfected with PNLIP. 
We next assessed the levels of BiP and calreticulin mRNA and splicing of XBP1 mRNA in 
AR42J cells transduced with adenovirus constructs at various titers.  In these cells there was a 
robust upregulation of BiP in cells transduced with p.T221M PNLIP adenovirus compared to 
cells transduced with control or PNLIP adenovirus (Fig. 5A).  The increase in BiP mRNA was 
about 18-fold above the levels in control cells at the highest viral titer tested (P ≤ 0.01).  In 
contrast to the findings in HEK 293A cells, there was an 11-fold upregulation of calreticulin 
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mRNA in the cells transduced with the highest titers of p.T221M PNLIP adenovirus (P ≤ 0.05) 
(Fig. 5B).  Like the HEK 293A cells, the expression of p.T221M PNLIP in AR42J cells caused an 
increase in XBP1 mRNA splicing compared to the levels in cells expressing PNLIP (P ≤ 0.001) 
(Fig. 5C). 
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4. Discussion 
4.1 Misfolding of p.T221M PNLIP 
In this study, we determined the effect of the p.T221M PNLIP substitution mutation on the 
function of PNLIP. The mutation was recently identified in subjects with clinical PNLIP 
deficiency. On the basis of structural modeling it was suggested that p.T221M should impair 
enzymatic activity of PNLIP which would explain the clinical phenotype of PNLIP deficiency.  
Our results demonstrated absent lipase activity and a marked secretion defect of p.T221M 
PNLIP expressed in two cell culture models.  The secretion defect is a result of misfolding and 
accumulation of p.T221M PNLIP inside the cells.  The presence of p.T221M in an insoluble 
intracellular fraction suggests the misfolded mutant protein forms aggregates, most likely in the 
ER. By extrapolation, it is unlikely that pancreatic acinar cells secrete p.T221M PNLIP to any 
significant extent.  A secretory defect would explain the steatorrhea reported in the two brothers 
carrying p.T221M PNLIP in the homozygous state (12). Unfortunately, lipase activity levels in 
the pancreatic secretions of the brothers were not reported.  The report documented low serum 
lipase levels in the two brothers and this finding in concert with steatorrhea was interpreted as 
evidence for a functional defect in p.T221M PNLIP activity.  The interpretation of the low serum 
lipase levels is complicated.  Although the method for measuring lipase activity is not reported, 
they were likely done in a clinical chemistry laboratory. The commercially available systems for 
measuring serum lipase activity are not specific for PNLIP and the low activity might be from 
other lipases such as carboxyl ester lipase or pancreatic lipase related protein 2 (PNLIPRP2) 
rather than from low levels of p.T221M PNLIP or normal protein levels of p.T221M PNLIP with 
low specific activity. 
 
4.2 Comparison of PNLIP deficiency in humans and mice 
The clinical course of the two brothers resembles that reported for other patients with 
probable PNLIP deficiency (1-10).  The major clinical symptom was greasy, voluminous stools.  
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Poor growth was not present in the brothers or in the previously described patients.  In fact, the 
brothers’ compliance with pancreatic enzyme replacement therapy suffered because they were 
willing to cope with large, greasy stools after meals in exchange for an “inability to gain weight 
despite very high caloric intake (12).”  That is, the brothers were resistant to developing obesity.  
The inability to gain weight differentiated the two brothers from their unaffected family members.   
Preserved weight gain and resistance to obesity is mimicked in PNLIP-deficient mice (18, 
19).  Early in life, PNLIP-deficient mice gain weight normally (19).  But, when placed on a high-
fat, high-cholesterol diet and followed over a longer time, the PNLIP-deficient mice are resistant 
to the obesity that develops in wild-type mice (12).  The PNLIP-deficient mice weigh less and 
have less fat body mass than the wild-type mice fed the same diet. 
The presence of significant steatorrhea in the humans with PNLIP deficiency differs from the 
phenotype of PNLIP-deficient mice.  The mice have minimal to no steatorrhea depending on the 
method used to measure fat absorption (18, 19).  The explanation for this difference is unclear 
and is further confounded by results in colipase-deficient mice.  Adult colipase-deficient mice 
have significant steatorrhea on a high-fat, high cholesterol diet (20).  Since mouse PNLIP is 
dependent on colipase for activity in the presence of micellar concentrations of bile salts and 
PNLIP is the predominant colipase-dependent lipase secreted by the pancreas, the effect of 
colipase deficiency was attributed to deficient PNLIP activity (21-23). 
 
4.3 The role of PNLIPRP2 and CEL in compensating for PNLIP deficiency in humans and mice 
The combination of steatorrhea in colipase-deficient mice but not in PNLIP-deficient mice 
suggests other lipases contribute to fat digestion in adult mice.  To this point, mice deficient in 
both PNLIP and carboxyl ester lipase had steatorrhea although they still absorbed about 60% of 
the fat in the high-fat, high-cholesterol diet (18). The authors suggested that PNLIPRP2 might 
account for some of the remaining fat digestion.  PNLIPRP2 activity is stimulated by colipase 
and it accounts for all of the colipase-dependent lipase activity in the pancreas of a newborn 
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mouse, an age when PNLIP is not expressed (21, 24).  It is plausible that carboxyl ester lipase 
and PNLIPRP2 compensate for the loss of PNLIP in the PNLIP-deficient mice.   
In the case of these brothers, it appears that PNLIPRP2 and CEL cannot compensate for 
the loss of PNLIP and the result is steatorrhea.  The reason for this may lay in the marked 
differences in enzyme kinetics between the mouse and human PNLIPRP2 lipases (21, 25).  In 
particular the specific activity of mouse PNLIPRP2 against long-chain triglycerides, the major 
dietary fat, is about 7-fold greater than the activity of human PNLIPRP2 even under optimal 
conditions (21, 26).  In fact, the specific activity of mouse PNLIPRP2 against long chain 
triglycerides is only slightly lower than the specific activity of mouse PNLIP.  Furthermore, 
mouse PNLIPRP2 has 10-fold higher specific activity against short and medium chain 
triglycerides than human PNLIPRP2.  The higher specific activity may allow mouse PNLIPRP2 
to adequately compensate for the absence of PNLIP in PNLIP-deficient mice. 
 
4.4 ER stress response 
The second important finding of our study is the up-regulation of the ER stress response in 
cells expressing p.T221M PNLIP.  A robust ER stress response can activate cell-death 
pathways, which could potentially damage the pancreas.  This mechanism has been suggested 
for other misfolding variants of PRSS1, CTRC and CPA1 (27-29).  Each of these variants 
increases ER stress in transfected cells and are risk factors for chronic pancreatitis in humans.  
The accumulation of misfolded p.T221M PNLIP could also increase the risk for chronic 
pancreatitis.  In the report of the two brothers, there are suggestions that they had pancreatic 
insufficiency and not just PNLIP deficiency.  In addition to steatorrhea, low serum carnitine and 
low serum vitamin E levels, both brothers had low fecal elastase levels and the proband had an 
abnormal pancreolauryl test.  Neither brother had evidence for an intestinal mucosal defect that 
might impair fatty acid absorption.  No radiographic imaging of the pancreas was reported so it 
is not known if the brothers’ pancreas had anatomic abnormalities consistent with chronic 
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pancreatitis.  Even so, the available data suggests that the p.T221M PNLIP may have broader 
affects not limited to fat digestion.  Although the p.T221M PNLIP mutation has only been 
reported in a single consanguineous family, the possibility that other mutations in PNLIP 
increase the risk for pancreatic disease should be considered. 
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FIGURE LEGENDS 
Fig. 1. Secretion of PNLIP and p.T221M PNLIP from transfected HEK 293A cells.  The media 
from transfected cells was sampled 72 hr after transfection.  (A) The lipase activity against 
tributyrin in 50 µl of medium was measured in the standard 5 minute pH-stat assay.  The mean 
and SD of 3 separate determinations is plotted.  (B) The presence of PNLIP was determined by 
SDS PAGE and protein immunoblot with the rabbit anti-human PNLIP antisera followed by 
detection with the HRP conjugated goat anti-rabbit IgG antisera. (C) The relative amounts of 
lipase in the samples were determined by densitometry of 3 separate experiments.   
 
Fig. 2. The intracellular accumulation of PNLIP and p.T221M PNLIP in transfected HEK 293A 
cells.  Seventy-two hours after transfection the cells were harvested and processed for total, 
soluble and insoluble fractions as described in Materials and Methods. The presence of PNLIP 
was determined by SDS PAGE and protein immunoblot with the rabbit anti-human PNLIP 
antisera followed by detection with the HRP conjugated goat anti-rabbit IgG antisera.  The 
relative amounts of lipase in the samples were determined by densitometry.  The mean and SD 
of 3 separate determinations is plotted.  (A) The total amount of PNLIP and p.T221M PNLIP are 
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shown.  GAPDH serves as the loading control.  (B) The amount of each lipase in the soluble 
intracellular fraction is shown. (C) The amount of each lipase in the insoluble intracellular 
fraction is shown.  ***P ≤ 0.001. 
 
Fig. 3. Expression of PNLIP and p.T221M PNLIP in adenovirus transduced AR42J cells.  The 
cells were transduced with three different titers of adenovirus.  (A) Aliquots of conditioned 
medium were assayed by SDS PAGE followed by Coomassie Blue staining (upper panel) or by 
protein immunoblot with the HRP-conjugated mouse monoclonal penta-His antibody (middle 
panel) or were assayed for lipase activity against tributyrin in 100 µl of medium in the standard 5 
minute pH-stat assay (bottom panel).  The mean and SD of 3 separate determinations is 
plotted.  (B) Aliquots of total cell lysate were analyzed by SDS PAGE and protein immunoblot 
with the HRP-conjugated mouse monoclonal penta-His antibody.  α-tubulin was used as a 
loading control.  (C) AR42J cells were transfected with 108 pfu adenovirus and the total, soluble 
and insoluble fractions were analyzed by protein immunoblot.  ***P ≤ 0.001 
 
Fig. 4.  Effect of expression of p.T221M PNLIP in HEK 293A cells on ER stress.  Cellular 
lysates of transfected HEK 293A cells were prepared as described in Materials and Methods.  
At least three measurements from separate experiments were done in each case.  (A) The 
relative amounts of BiP determined by protein immunoblot and quantitated by densitometry.  (B) 
The relative amounts of calreticulin determined by protein immunoblot and quantitated by 
densitometry.  (C) The relative amounts of GRP94 determined by protein immunoblot and 
quantitated by densitometry. (D) Total RNA was isolated from transfected HEK 293A cells.  The 
amount of XBP1 mRNA splicing was measured by RT-PCR, separation by agarose gel 
electrophoresis, ethidium bromide staining and densitometry.  The upper panel is a 
representative agarose gel of the RT-PCR products.  The bottom panel is the amount of XBP1 
mRNA splicing quantitated by densitometry.  **P ≤ 0.01. 
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 Fig. 5. Effect of expression of p.T221M PNLIP in AR42J cells on ER stress.  The cells were 
transduced with three different titers of each adenovirus construct.  Total RNA was isolated from 
the cells as described.  The amount of mRNA encoding BiP and calreticulin was determined by 
real-time RT-PCR and the amount of XBP1 mRNA splicing determined by RT-PCR, separation 
by agarose gel electrophoresis, ethidium bromide staining and densitometry.  (A) Mean and SD 
of the relative BiP levels.  (B) Mean and SD of the relative calreticulin levels. (C) Amount of 
XBP1 mRNA splicing is given.  The upper panel shows a representative agarose gel separation 
of the RT-PCR products.  The bottom panel presents the mean and SD of 3 experiments.   *P ≤ 
0.05; **P ≤ 0.01; ***P ≤ 0.001 
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